Elizabeth Navarro

1.0k total citations
14 papers, 789 citations indexed

About

Elizabeth Navarro is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Elizabeth Navarro has authored 14 papers receiving a total of 789 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Cell Biology and 4 papers in Oncology. Recurrent topics in Elizabeth Navarro's work include Proteoglycans and glycosaminoglycans research (6 papers), Glycosylation and Glycoproteins Research (4 papers) and Fibroblast Growth Factor Research (4 papers). Elizabeth Navarro is often cited by papers focused on Proteoglycans and glycosaminoglycans research (6 papers), Glycosylation and Glycoproteins Research (4 papers) and Fibroblast Growth Factor Research (4 papers). Elizabeth Navarro collaborates with scholars based in United States. Elizabeth Navarro's co-authors include Paul Kussie, Hua‐Quan Miao, Dale L. Ludwig, Sheetal Patel, Zhenping Zhu, Peter Böhlen, Hu Liu, Nicholas A. Giorgio, Andrew P. Seddon and Paul Balderes and has published in prestigious journals such as Blood, Cancer Research and Clinical Cancer Research.

In The Last Decade

Elizabeth Navarro

14 papers receiving 767 citations

Peers

Countries citing papers authored by Elizabeth Navarro

Since Specialization

Citations

This map shows the geographic impact of Elizabeth Navarro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Navarro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Navarro more than expected).

Fields of papers citing papers by Elizabeth Navarro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Navarro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Navarro. The network helps show where Elizabeth Navarro may publish in the future.

Co-authorship network of co-authors of Elizabeth Navarro

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Navarro. A scholar is included among the top collaborators of Elizabeth Navarro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Navarro. Elizabeth Navarro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	A CD38xCD28 Costimulatory Bispecific Antibody Demonstrates Potent Preclinical Combinatorial Activity with a BCMAxCD3 T Cell-Engager 2024 ·Blood ·Kara Olson, David J. DiLillo, Olga Sineshchekova, Katja Mohrs, (unknown), (unknown), (unknown), Steven Quatela, Elizabeth Navarro, Cuiyan Lin, (unknown), Glenn S. Kroog, Karen Rodriguez Lorenc, Erica Ullman, Aynur Hermann, Eric E. Smith, Jessica R. Kirshner, William C. Olson, John Lin	1
2	Antibody drug conjugates of cleavable amino-benzoyl-maytansinoids 2020 ·Bioorganic & Medicinal Chemistry ·Thomas Nittoli, Frank J. Delfino, Marcus P. Kelly, (unknown), (unknown), Arthur Kunz, Zhaoyuan Chen, Shu Mao, Jing Shan, Elizabeth Navarro, Feng Zhao, Sosina Makonnen, Carlos Hickey, (unknown), William C. Olson, Jessica R. Kirshner, Gavin Thurston, Nicholas Papadopoulos	4
3	Abstract 4835: LY3076226, a novel anti-FGFR3 antibody drug conjugate exhibits potent and durable anti-tumor activity in tumor models harboring FGFR3 mutations or fusions 2019 ·David Surguladze, (unknown), Xiaodi Ren, (unknown), Alan S. Rigby, Paul Balderes, Elizabeth Navarro, Nelusha Amaladas, Scott Eastman, Michael J. Topper, Yung‐Mae Yao, (unknown), Gregory D. Plowman, Dale L. Ludwig	1
4	Abstract 4835: LY3076226, a novel anti-FGFR3 antibody drug conjugate exhibits potent and durable anti-tumor activity in tumor models harboring FGFR3 mutations or fusions 2019 ·Cancer Research ·David Surguladze, (unknown), (unknown), (unknown), Alan C. Rigby, Paul Balderes, Elizabeth Navarro, Nelusha Amaladas, Scott W. Eastman, (unknown), Yung‐Mae Yao, (unknown), Gregory D. Plowman, Dale L. Ludwig	8
5	The Structural Basis for the Function of Two Anti-VEGF Receptor 2 Antibodies 2011 ·Structure ·Matthew C. Franklin, Elizabeth Navarro, Yujie Wang, Sheetal Patel, (unknown), Yi Zhang, Kris Persaud, (unknown), Heather Griffith, Leyi Shen, Paul Balderes, Paul Kussie	44
6	Development of Heparanase Inhibitors for Anti-Cancer Therapy 2006 ·Current Medicinal Chemistry ·Zhenping Zhu, Elizabeth Navarro, Paul Kussie, Hu Liu, Hua‐Quan Miao	88
7	Potent neutralization of VEGF biological activities with a fully human antibody Fab fragment directed against VEGF receptor 2 2006 ·Biochemical and Biophysical Research Communications ·Hua‐Quan Miao, (unknown), Xenia Jimenez, Elizabeth Navarro, Haifan Zhang, Dan Lu, Dale L. Ludwig, Paul Balderes, Zhenping Zhu	79
8	Anti-Vascular Endothelial Growth Factor Receptor-1 Antagonist Antibody as a Therapeutic Agent for Cancer 2006 ·Clinical Cancer Research ·Yan Wu, Zhaojing Zhong, James Huber, Rajiv Bassi, Bridget Finnerty, Erik Corcoran, Huiling Li, Elizabeth Navarro, Paul Balderes, Xenia Jimenez, Henry Koo, (unknown), Dale L. Ludwig, James R. Tonra, Daniel J. Hicklin	120
9	N-(4-{[4-(1H-Benzoimidazol-2-yl)-arylamino]-methyl}-phenyl)-benzamide derivatives as small molecule heparanase inhibitors 2005 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Hua‐Quan Miao, Weitao Pan, Elizabeth Navarro, James R. Tonra, (unknown), (unknown), Dhanvanthri S. Deevi, Alexander S. Kiselyov, Paul Kussie, Wai C. Wong, Hu Liu	39
10	1-[4-(1H-Benzoimidazol-2-yl)-phenyl]-3-[4-(1H-benzoimidazol-2-yl)-phenyl]-urea derivatives as small molecule heparanase inhibitors 2005 ·Bioorganic & Medicinal Chemistry Letters ·Weitao Pan, Hua‐Quan Miao, Yongjiang Xu, Elizabeth Navarro, James R. Tonra, Erik Corcoran, (unknown), Paul Kussie, Alexander S. Kiselyov, Wai C. Wong, Hu Liu	53
11	High heparanase activity in multiple myeloma is associated with elevated microvessel density. 2003 ·PubMed ·Thomas J. Kelly, Hua‐Quan Miao, Yang Yang, Elizabeth Navarro, Paul Kussie, Yan Huang, Veronica MacLeod, (unknown), Lija Joseph, Fenghuang Zhan, Maurizio Zangari, Bart Barlogie, John D. Shaughnessy, Ralph D. Sanderson	146
12	Cloning, expression, and purification of mouse heparanase 2002 ·Protein Expression and Purification ·Hua‐Quan Miao, Elizabeth Navarro, Sheetal Patel, David F. Sargent, Henry Koo, (unknown), (unknown), Qinwei Zhou, Dale L. Ludwig, Peter Böhlen, Paul Kussie	35
13	Cloning and Functional Expression of a Human Heparanase Gene 1999 ·Biochemical and Biophysical Research Communications ·Paul Kussie, Jeffrey D. Hulmes, Dale L. Ludwig, Sheetal Patel, Elizabeth Navarro, Andrew P. Seddon, Nicholas A. Giorgio, Peter Böhlen	170
14	[Biochemical studies of the behavior of 5 isoenzymes of lactate dehydrogenase in normal and pathological leukocytes]. 1973 ·PubMed ·(unknown), Elizabeth Navarro	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact